Form 8K Current Report
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15 (d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): June 9, 2006
SIGA
TECHNOLOGIES, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
0-23047
|
13-3864870
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
file number)
|
(I.R.S.
employer
identification
no.)
|
420
Lexington Avenue, Suite 408
New
York, New York
(Address
of principal executive offices)
|
|
10170
(Zip
code)
|
Registrant’s
telephone number, including area code: (212) 672-9100
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
r
Written
communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
x
Soliciting
material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
r
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
r
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01. Other
Events.
On
June
9, 2006, SIGA Technologies, Inc., a Delaware corporation (“SIGA”) and
PharmAthene, Inc., a Delaware corporation (“PharmAthene”), issued a joint press
release pursuant to which they announced that they have entered into a
definitive agreement providing for the merger of PharmAthene and SIGA. A copy
of
the press release is attached hereto as Exhibit 99.1, which is incorporated
by
reference in this Item 8.01.
A
copy of
the Agreement and Plan of Merger, dated as of June 8, 2006, among SIGA, its
wholly owned subsidiary, SIGA Acquisition Corp., a Delaware corporation, and
PharmAthene is publicly available as an exhibit to SIGA’s previous Form 8-K
filed on June 13, 2006.
Item
9.01. Financial Statements and Exhibits.
(c) Exhibits
Exhibit
No.
|
Description
|
99.1
|
Press
Release dated June 9, 2006.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
SIGA
TECHNOLOGIES,
INC.
By:
/s/
Thomas N.
Konatich
Name:
Thomas
N.
Konatich
Title:
Acting
Chief Executive Officer & Chief Financial Officer
Date: June
13,
2006